145 related articles for article (PubMed ID: 38131642)
1. Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer.
Coco C; Delrio P; Rega D; Amodio LE; Pucciarelli S; Spolverato G; Belluco C; Lauretta A; Poggioli G; Rocco G; Bianco F; Marsanic P; Sica G; Tondolo V; Rizzo G;
Colorectal Dis; 2024 Feb; 26(2):281-289. PubMed ID: 38131642
[TBL] [Abstract][Full Text] [Related]
2. Local excision after neoadjuvant chemoradiotherapy versus total mesorectal excision: a case-matched study in 110 selected high-risk patients with rectal cancer.
Calmels M; Collard MK; Cazelles A; Frontali A; Maggiori L; Panis Y
Colorectal Dis; 2020 Dec; 22(12):1999-2007. PubMed ID: 32813899
[TBL] [Abstract][Full Text] [Related]
3. Short-term outcomes of transanal completion total mesorectal excision (cTaTME) for rectal cancer: a case-matched analysis.
Koedam TWA; Veltcamp Helbach M; Penna M; Wijsmuller A; Doornebosch P; van Westreenen HL; Hompes R; Bonjer HJ; Sietses C; de Graaf E; Tuynman JB
Surg Endosc; 2019 Jan; 33(1):103-109. PubMed ID: 29967991
[TBL] [Abstract][Full Text] [Related]
4. Local versus radical surgery for early rectal cancer with or without neoadjuvant or adjuvant therapy.
Motamedi MAK; Mak NT; Brown CJ; Raval MJ; Karimuddin AA; Giustini D; Phang PT
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD002198. PubMed ID: 37310167
[TBL] [Abstract][Full Text] [Related]
5. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
[TBL] [Abstract][Full Text] [Related]
6. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
7. Comparing neoadjuvant therapy followed by local excision to total mesorectal excision in the treatment of early stage rectal cancer: a systematic review and meta-analysis of randomised clinical trials.
Lynch P; Ryan OK; Donnelly M; Ryan ÉJ; Davey MG; Reynolds IS; Creavin B; Hanly A; Kennelly R; Martin ST; Winter DC
Int J Colorectal Dis; 2023 Nov; 38(1):263. PubMed ID: 37924372
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant-intensified treatment for rectal cancer: time to change?
Musio D; De Felice F; Bulzonetti N; Guarnaccia R; Caiazzo R; Bangrazi C; Raffetto N; Tombolini V
World J Gastroenterol; 2013 May; 19(20):3052-61. PubMed ID: 23716984
[TBL] [Abstract][Full Text] [Related]
9. Local excision after neoadjuvant chemoradiotherapy for mid and low rectal cancer: a multicentric French study from the GRECCAR group.
Calmels M; Labiad C; Lelong B; Lefevre JH; Tuech JJ; Benoist S; Mège D; Denost Q; Panis Y
Colorectal Dis; 2023 Oct; 25(10):1973-1980. PubMed ID: 37679892
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution.
van Groningen JT; van Hagen P; Tollenaar RAEM; Tuynman JB; de Mheen PJM; Doornebosch PG; Tanis PJ; de Graaf EJR;
J Natl Compr Canc Netw; 2018 Jul; 16(7):822-828. PubMed ID: 30006424
[No Abstract] [Full Text] [Related]
11. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
12. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
[TBL] [Abstract][Full Text] [Related]
13. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
14. Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer.
Rizzo G; Zaccone G; Magnocavallo M; Mattana C; Pafundi DP; Gambacorta MA; Valentini V; Coco C
Eur J Surg Oncol; 2017 Aug; 43(8):1488-1493. PubMed ID: 28583790
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.
Sauer R; Fietkau R; Wittekind C; Rödel C; Martus P; Hohenberger W; Tschmelitsch J; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R;
Colorectal Dis; 2003 Sep; 5(5):406-15. PubMed ID: 12925071
[TBL] [Abstract][Full Text] [Related]
16. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
[TBL] [Abstract][Full Text] [Related]
17. Local excision followed by early radical surgery in rectal cancer: long-term outcome.
Junginger T; Goenner U; Hitzler M; Trinh TT; Heintz A; Wollschläger D
World J Surg Oncol; 2019 Oct; 17(1):168. PubMed ID: 31594546
[TBL] [Abstract][Full Text] [Related]
18. Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study).
Serra-Aracil X; Pericay C; Badia-Closa J; Golda T; Biondo S; Hernández P; Targarona E; Borda-Arrizabalaga N; Reina A; Delgado S; Vallribera F; Caro A; Gallego-Plazas J; Pascual M; Álvarez-Laso C; Guadalajara-Labajo HG; Mora-Lopez L
Ann Oncol; 2023 Jan; 34(1):78-90. PubMed ID: 36220461
[TBL] [Abstract][Full Text] [Related]
19. Routine defunctioning stoma after chemoradiation and total mesorectal excision: a single-surgeon experience.
Lin SC; Chen PC; Lee CT; Tsai HM; Lin PC; Chen HH; Wu YH; Lin BW; Su WP; Lee JC
World J Gastroenterol; 2013 Mar; 19(11):1797-804. PubMed ID: 23555168
[TBL] [Abstract][Full Text] [Related]
20. Transanal local excision versus intersphincteric resection for low rectal cancer with stage ypT0-1ycN0 after neoadjuvant chemoradiotherapy: an inverse probability weighting analysis for oncological and functional outcomes.
Pan H; Gao Y; Ruan H; Chi P; Huang Y; Huang S
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17383-17394. PubMed ID: 37843558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]